including stroke, heart failure, and even death. Yet, the current standard of care — including antiarrhythmic drugs and anatomically-based ablation therapy — is suboptimal and is associated with severe side effects and disappointingly low success rates.¹
The vMap™ system is the first non-invasive mapping tool that uses only 12-lead ECG data to help physicians rapidly locate potential cardiac arrhythmia sources with precision.
